用芬戈莫德治疗的患者出现早期复发性黄斑水肿。 - Suppr

Early and recurrent macular oedema in a patient treated with fingolimod.

作者信息

Cifuentes-Canorea P, Nieves-Moreno M, Sáenz-Francés F, Santos-Bueso E

机构信息

Unidad de Neurooftalmología, Servicio de Oftalmología, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, España.

出版信息

Neurologia (Engl Ed). 2019 Apr;34(3):206-207. doi: 10.1016/j.nrl.2016.08.005. Epub 2016 Oct 21.

DOI:10.1016/j.nrl.2016.08.005

PMID:27776961

Abstract

摘要

相似文献

Early and recurrent macular oedema in a patient treated with fingolimod.

Neurologia (Engl Ed). 2019 Apr;34(3):206-207. doi: 10.1016/j.nrl.2016.08.005. Epub 2016 Oct 21.

Fingolimod-associated macular oedema.

BMJ Case Rep. 2017 Jun 15;2017:bcr-2016-218912. doi: 10.1136/bcr-2016-218912.

Longitudinal quantitative assessment of macula during therapy with fingolimod in relapsing-remitting multiple sclerosis.

Int Ophthalmol. 2019 Apr;39(4):777-781. doi: 10.1007/s10792-018-0870-x. Epub 2018 Mar 2.

Real-world incidence of fingolimod-associated macular oedema.

Mult Scler Relat Disord. 2020 Jul;42:102125. doi: 10.1016/j.msard.2020.102125. Epub 2020 Apr 28.

Famous.

Surv Ophthalmol. 2016 Jul-Aug;61(4):512-9. doi: 10.1016/j.survophthal.2015.12.008. Epub 2015 Dec 29.

Acetazolamide therapy in a case of fingolimod-associated macular edema: early benefits and long-term limitations.

Mult Scler Relat Disord. 2015 Sep;4(5):406-408. doi: 10.1016/j.msard.2015.06.015. Epub 2015 Jul 2.

Does fingolimod in multiple sclerosis patients cause macular edema?

J Neurol. 2012 Feb;259(2):386-8. doi: 10.1007/s00415-011-6367-4. Epub 2012 Jan 10.

Improvement of macular edema without discontinuation of fingolimod in a patient with multiple sclerosis: A case report.

Medicine (Baltimore). 2016 Jul;95(29):e4180. doi: 10.1097/MD.0000000000004180.

Safety and tolerability of fingolimod in patients with relapsing-remitting multiple sclerosis: results of an open-label clinical trial in Italy.

Neurol Sci. 2017 Jan;38(1):53-59. doi: 10.1007/s10072-016-2701-z. Epub 2016 Oct 18.

Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis.

Ophthalmic Plast Reconstr Surg. 2017 May/Jun;33(3):e73-e75. doi: 10.1097/IOP.0000000000000774.

引用本文的文献

BMC Pharmacol Toxicol. 2025 Jan 30;26(1):23. doi: 10.1186/s40360-025-00856-9.

Diagnosis and Management of Fingolimod-Associated Macular Edema.

Front Neurol. 2022 Jul 15;13:918086. doi: 10.3389/fneur.2022.918086. eCollection 2022.

Ocular adverse events from pharmacological treatment in patients with multiple sclerosis-A systematic review of the literature.

Syst Rev. 2021 Oct 28;10(1):280. doi: 10.1186/s13643-021-01782-7.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Early and recurrent macular oedema in a patient treated with fingolimod.

Neurologia (Engl Ed). 2019 Apr;34(3):206-207. doi: 10.1016/j.nrl.2016.08.005. Epub 2016 Oct 21.

Fingolimod-associated macular oedema.

BMJ Case Rep. 2017 Jun 15;2017:bcr-2016-218912. doi: 10.1136/bcr-2016-218912.

Longitudinal quantitative assessment of macula during therapy with fingolimod in relapsing-remitting multiple sclerosis.

Int Ophthalmol. 2019 Apr;39(4):777-781. doi: 10.1007/s10792-018-0870-x. Epub 2018 Mar 2.

Real-world incidence of fingolimod-associated macular oedema.

Mult Scler Relat Disord. 2020 Jul;42:102125. doi: 10.1016/j.msard.2020.102125. Epub 2020 Apr 28.

Famous.

Surv Ophthalmol. 2016 Jul-Aug;61(4):512-9. doi: 10.1016/j.survophthal.2015.12.008. Epub 2015 Dec 29.

Acetazolamide therapy in a case of fingolimod-associated macular edema: early benefits and long-term limitations.

Mult Scler Relat Disord. 2015 Sep;4(5):406-408. doi: 10.1016/j.msard.2015.06.015. Epub 2015 Jul 2.

Does fingolimod in multiple sclerosis patients cause macular edema?

J Neurol. 2012 Feb;259(2):386-8. doi: 10.1007/s00415-011-6367-4. Epub 2012 Jan 10.

Improvement of macular edema without discontinuation of fingolimod in a patient with multiple sclerosis: A case report.

Medicine (Baltimore). 2016 Jul;95(29):e4180. doi: 10.1097/MD.0000000000004180.

Safety and tolerability of fingolimod in patients with relapsing-remitting multiple sclerosis: results of an open-label clinical trial in Italy.

Neurol Sci. 2017 Jan;38(1):53-59. doi: 10.1007/s10072-016-2701-z. Epub 2016 Oct 18.

Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis.

Ophthalmic Plast Reconstr Surg. 2017 May/Jun;33(3):e73-e75. doi: 10.1097/IOP.0000000000000774.

引用本文的文献

BMC Pharmacol Toxicol. 2025 Jan 30;26(1):23. doi: 10.1186/s40360-025-00856-9.

Diagnosis and Management of Fingolimod-Associated Macular Edema.

Front Neurol. 2022 Jul 15;13:918086. doi: 10.3389/fneur.2022.918086. eCollection 2022.

Ocular adverse events from pharmacological treatment in patients with multiple sclerosis-A systematic review of the literature.

Syst Rev. 2021 Oct 28;10(1):280. doi: 10.1186/s13643-021-01782-7.

Early and recurrent macular oedema in a patient treated with fingolimod.

作者信息

Cifuentes-Canorea P, Nieves-Moreno M, Sáenz-Francés F, Santos-Bueso E

机构信息

Unidad de Neurooftalmología, Servicio de Oftalmología, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, España.

出版信息

Neurologia (Engl Ed). 2019 Apr;34(3):206-207. doi: 10.1016/j.nrl.2016.08.005. Epub 2016 Oct 21.

DOI:10.1016/j.nrl.2016.08.005

PMID:27776961

Abstract

摘要

Early and recurrent macular oedema in a patient treated with fingolimod.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

Early and recurrent macular oedema in a patient treated with fingolimod.

作者信息

机构信息

出版信息